This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 3. Summary of benefits and harms of screening 1000 high-risk pregnant
women for bacterial vaginosis1
| Benefit
and relevant factors |
"General"
high-risk groupa |
"More
selected" high-risk groupb |
| Assumptions |
| Proportion
of pregnant women who meet screening criteria |
0.1 |
0.03 |
| Prevalence
of BV in population |
0.25 |
0.25 |
| Relative
risk of PTD in BV patients |
1.6 |
1.6 |
| Sensitivity
of screening test |
0.95 |
0.95 |
| Specificity
of screening test |
0.95 |
0.95 |
| Adherence
to treatment |
0.8 |
0.8 |
| Effect
sizes, BV patients (probability: control group vs treated group [CI])c |
| PTD
<37 weeks |
-0.075(-0.19
to +0.04) |
+0.22(+0.13
to +0.31) |
| PPROM |
-0.04(-0.101
to +0.03) |
+0.29(+0.15
to +0.43) |
| PTD
<34 weeks |
+0.012(-0.06
to 0.08) |
+0.06(+0.01
to +0.15) |
| Effect
sizes, patients without BV (probability: control group vs treated group)c |
| PTD
<37 weeks |
0 |
0 |
| PPROM |
0 |
0 |
| PTD
<34 weeks |
-0.02 |
-0.06 |
| Results
(n) |
| Patients
with unsuspected BV |
250 |
250 |
| Correctly
diagnosed with BV |
238 |
238 |
| BV
patients who complete therapy |
190 |
190 |
| BV
patients with missed diagnosis |
13 |
13 |
| Incorrectly
diagnosed with BV |
38 |
38 |
| Outcomesc |
| Decrease
or increase in PTD <37 weeks (CI) |
-14(-36
to +7) |
+42(+25
to +59) |
| Decrease
or increase in PPROM |
-8(-19
to +4) |
+49(+28
to +70) |
| Decrease
or increase in PTD <34 weeks |
+2(-11
to +14) |
+9(-2
to +19) |
a Screen all women who have at least one previous
PTD.
b Screen if there is more than one previous
PTD or other risk factors.
c Minus sign indicates a net increase, plus
indicates a net decrease, in adverse effects.
1 BV, bacterial vaginosis; PTD, preterm delivery;
CI, confidence interval; PPROM, preterm premature rupture of membranes. |
Return to Document